VERACYTE, INC. Recognition of Deferred Revenue
VERACYTE, INC. (VCYT) reported Recognition of Deferred Revenue of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2018-02-27
- VERACYTE, INC. recognition of deferred revenue for the quarter ending 2017-12-31 was $0.00.
- VERACYTE, INC. recognition of deferred revenue for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- VERACYTE, INC. recognition of deferred revenue for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- VERACYTE, INC. recognition of deferred revenue for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- VERACYTE, INC. recognition of deferred revenue for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- VERACYTE, INC. recognition of deferred revenue for fiscal 2016 was $948.00K, a 50.03% decline from fiscal 2015.
- VERACYTE, INC. recognition of deferred revenue for fiscal 2015 was $1.90M, a 16.39% decline from fiscal 2014.
- VERACYTE, INC. recognition of deferred revenue for fiscal 2014 was $2.27M, a 9.24% decline from fiscal 2013.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 9 month | Recognition of Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $0.00 10-Q · filed 2017-07-31 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $227.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-03 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $227.00K derived: sum of 3 quarters · filed 2018-02-27 | $518.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $227.00K derived: sum of 2 quarters · filed 2018-02-27 | $518.00K derived: sum of 3 quarters · filed 2018-02-27 | $948.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $518.00K derived: sum of 2 quarters · filed 2017-11-07 | $948.00K 10-Q · filed 2017-11-07 | $1.42M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $721.00K 10-Q · filed 2017-07-31 | $1.20M derived: sum of 3 quarters · filed 2018-02-27 | $1.67M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $430.00K 10-Q · filed 2017-05-03 | $904.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.38M derived: sum of 3 quarters · filed 2018-02-27 | $1.85M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $948.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.42M derived: sum of 3 quarters · filed 2018-02-27 | $1.90M 10-K · filed 2018-02-27 |
| 2015-09-30 | $474.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $949.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.42M 10-Q · filed 2016-11-03 | $1.90M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $475.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $949.00K 10-Q · filed 2016-08-03 | $1.42M derived: sum of 3 quarters · filed 2017-03-01 | $1.97M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $474.00K 10-Q · filed 2016-05-05 | $949.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.49M derived: sum of 3 quarters · filed 2017-03-01 | $2.12M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $475.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.02M derived: sum of 2 quarters · filed 2017-03-01 | $1.64M derived: sum of 3 quarters · filed 2017-03-01 | $2.27M 10-K · filed 2017-03-01 |
| 2014-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.17M derived: sum of 2 quarters · filed 2015-11-05 | $1.79M 10-Q · filed 2015-11-05 | $2.42M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $625.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.25M 10-Q · filed 2015-08-13 | $1.88M derived: sum of 3 quarters · filed 2016-03-14 | $2.50M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $625.00K 10-Q · filed 2015-05-15 | $1.25M derived: sum of 2 quarters · filed 2016-03-14 | $1.88M derived: sum of 3 quarters · filed 2016-03-14 | $2.50M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.25M derived: sum of 2 quarters · filed 2016-03-14 | $1.88M derived: sum of 3 quarters · filed 2016-03-14 | $2.50M 10-K · filed 2016-03-14 |
| 2013-09-30 | $625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.25M derived: sum of 2 quarters · filed 2014-11-13 | $1.88M 10-Q · filed 2014-11-13 | $2.50M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-06-30 | $625.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.25M 10-Q · filed 2014-08-14 | $1.88M derived: sum of 3 quarters · filed 2015-03-25 | |
| 2013-03-31 | $625.00K 10-Q · filed 2014-05-09 | $1.25M derived: sum of 2 quarters · filed 2015-03-25 | ||
| 2012-12-31 | $625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $2.39M 10-K · filed 2015-03-25 | ||
| 2012-09-30 | $1.76M 10-Q · filed 2013-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |